Vaccine goal indicators

in page functions

To accelerate equitable uptake and coverage of vaccines

Routine immunisation coverage

What we measure: percentage of children reached with the third dose of a vaccine containing antigens against diphtheria, tetanus and pertussis (DTP), such as pentavalent, and the first dose of measles vaccine in Gavi-supported countries. Universally present in the routine schedules of Gavi-supported countries, coverage estimates for these two vaccines provide a reliable indicator of the proportion of children with access to basic immunisation services.


Breadth of protection

What we measure: percentage of children reached with the last dose of seven vaccines recommended across all Gavi-supported countries and of three vaccines specific to certain regions.


Geography

What we measure: the percentage of countries we support in which coverage with a third dose of pentavalent vaccine is equal to or greater than 80% across all districts. As part of an increased effort to ensure accurate subnational data are available for measuring equity, WHO and UNICEF have started to report geographically disaggregated coverage data on an annual basis.


Poverty status

What we measure: the percentage of Gavi-supported countries in which coverage with a third dose of pentavalent vaccine among the poorest fifth of the population lies within 10 percentage points of the coverage among the richest 20%.


Education of mothers/female caregivers

What we measure: the percentage of Gavi-supported countries in which there is a less than 10 percentage point difference in immunisation coverage between children of non-educated mothers and those whose mothers have at least completed secondary school. We use three doses of pentavalent vaccine as the basis for this indicator.

The poverty status and female education indicators are based on survey data. Due to limited availability of this data, and the implications this has for interpreting trends over time and across Gavi-supported countries, we are not presenting these indicators at this time. We continue to use equity data to drive our coverage and equity work in countries, and will report on individual countries where appropriate. We will give a full update of these indicators at the mid-term (2018) and end of our current strategy period (2020).

 

>100 million

Since 2011, Gavi-supported yellow fever campaigns have protected over 98 million people in 14 countries. We have also helped 17 countries introduce yellow fever vaccine through routine immunisation, immunising more than 100 million children.

Gavi

More facts...

close icon

modal window here